ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.91
0.23%
US Tech 100
19,003.60
0.74%
S&P 500
5,586.62
0.26%
US Dollar vs CAD
1.43982
-0.24%
Bitcoin
81,610.23
-1.50%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Maravai LifeSciences Holdings Inc (MRVI) Share Price

Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

NASDAQ
2.665
0.025
( 0.95% )
Updated: 10:28:21
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.665
Bid
2.66
Ask
2.67
Volume
398,678
2.61 Day's Range 2.68
2.595 52 Week Range 11.555
Market Cap
672.986M
Previous Close
2.64
Open
2.64
Last Trade
2
@
2.665
Last Trade Time
10:28:41
Financial Volume
US$ 1,053,022
VWAP
2.6413
Average Volume (3m)
2,829,037
Shares Outstanding
252,527,585
Dividend Yield
-
PE Ratio
-5.60
Earnings Per Share (EPS)
-0.47
Revenue
292.23M
Net Profit
-119.03M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was US$2.64. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 2.595 to US$ 11.555.

Maravai LifeSciences currently has 252,527,585 shares outstanding. The market capitalization of Maravai LifeSciences is US$666.67 million. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -5.60.

Ask ADVFN Intelligence (AI)

MRVI Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 19 2025
MRVI (0.95%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.145-5.160142348752.813.0552.59539814052.79723631CS
4-1.54-36.62306777654.2054.372.59546208493.32592087CS
12-3.085-53.6521739135.756.212.59528290374.07878475CS
26-6.215-69.98873873878.889.52.59522421205.20335265CS
52-5.015-65.29947916677.6811.5552.59522576386.92670805CS
156-35.345-92.988687187638.0141.822.595213197711.97517865CS
260-28.445-91.433622629431.1163.552.595196786618.36389266CS

MRVI - Frequently Asked Questions (FAQ)

What is the current Maravai LifeSciences share price?
The current share price of Maravai LifeSciences is US$ 2.665
How many Maravai LifeSciences shares are in issue?
Maravai LifeSciences has 252,527,585 shares in issue
What is the market cap of Maravai LifeSciences?
The market capitalisation of Maravai LifeSciences is USD 666.67M
What is the 1 year trading range for Maravai LifeSciences share price?
Maravai LifeSciences has traded in the range of US$ 2.595 to US$ 11.555 during the past year
What is the PE ratio of Maravai LifeSciences?
The price to earnings ratio of Maravai LifeSciences is -5.6
What is the cash to sales ratio of Maravai LifeSciences?
The cash to sales ratio of Maravai LifeSciences is 2.28
What is the reporting currency for Maravai LifeSciences?
Maravai LifeSciences reports financial results in USD
What is the latest annual turnover for Maravai LifeSciences?
The latest annual turnover of Maravai LifeSciences is USD 292.23M
What is the latest annual profit for Maravai LifeSciences?
The latest annual profit of Maravai LifeSciences is USD -119.03M
What is the registered address of Maravai LifeSciences?
The registered address for Maravai LifeSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Maravai LifeSciences operate in?
Maravai LifeSciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRVOCervoMed Inc
US$ 5.2235
(121.33%)
65.77M
AREBAmerican Rebel Holdings Inc
US$ 0.4592
(51.10%)
69.44M
VSTEVast Renewable Ltd
US$ 0.7022
(40.47%)
154.71M
GRPNGroupon Inc
US$ 13.14
(34.49%)
4.19M
OPRXOptimizeRx Corporation
US$ 5.474
(32.22%)
10.23M
ZYXIZynex Inc
US$ 3.635
(-48.07%)
979.91k
APDNApplied DNA Sciences Inc
US$ 0.0789
(-46.33%)
10.19M
HEPAHepion Pharmaceuticals Inc
US$ 0.0498
(-40.71%)
37.22M
SMSISmith Micro Software Inc
US$ 0.6899
(-35.82%)
841.79k
IRBTiRobot Corporation
US$ 4.1288
(-34.57%)
9.93M
STISolidion Technology Inc
US$ 0.161
(27.68%)
398.39M
VSTEVast Renewable Ltd
US$ 0.7022
(40.47%)
154.71M
NVDANVIDIA Corporation
US$ 114.2019
(5.00%)
122.47M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.85
(11.88%)
120.43M
AREBAmerican Rebel Holdings Inc
US$ 0.4591
(51.07%)
69.47M

MRVI Discussion

View Posts
Monksdream Monksdream 1 year ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 1 year ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

NASDAQ
MRVI
Maravai LifeSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads